The TB Alliance released its newest publication, Economics of TB Drug Development, which is the first analysis of the TB drug market in thirty years.
The study put today’s annual TB drug market at $450 million and growing to $700 million by the end of the decade. The study also estimates the cost of developing a lead compound through registration at just above $100 million.